Breast Cancer

EA1181 / CompassHER2 pCR

Preoperative THP & Postoperative HP in Patients who Achieve a Pathologic Complete Response

Part 1 Component of: The CompassHER2 Trials (COMprehensive use of Pathologic response ASSessment to optimize therapy in HER2 positive breast cancer

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

ECOG-ACRIN Cancer Research Group